Netrin-1 inducing antiapoptotic effect of acute myeloid leukemia cells in a concentration-dependent manner through the Unc-5 netrin receptor B-focal adhesion kinase axis

ABSTRACT Acute myeloid leukemia (AML) is a hematological malignancy that commonly occurs in children. The prognosis of pediatric AML is relatively poor, thus threatening the patient’s survival. The aberrant expression of the axon guidance factor, netrin-1, is observed in various types of malignancies, and it participates in the proliferation and apoptosis of tumor cells. Herein, we aimed to explore the role of netrin-1 in AML cells. Netrin-1 is highly expressed in AML patients. Proliferation and anti-apoptosis were observed in AML cells treated with netrin-1. The interaction between netrin-1 and Unc-5 netrin receptor B (UNC5B) was detected through coimmunoprecipitation, and UNC5B ribonucleic acid interference restrained the influence of netrin-1 on the AML cells. The phosphorylation of focal adhesion kinase-protein kinase B (FAK-Akt) was upregulated in AML cells treated with netrin-1. Both FAK and Akt inhibitors abrogated the effects of netrin-1 on the proliferation and apoptosis of AML cells. In conclusion, netrin-1 could promote the growth and reduce the apoptosis of AML cells in a concentration-dependent manner, and that these effects were mediated by activating the FAK-Akt signaling pathway via the UNC5B.

[1]  L. Xiao,et al.  Netrin-1 induces the anti-apoptotic and pro-survival effects of B-ALL cells through the Unc5b-MAPK axis , 2022, Cell communication and signaling : CCS.

[2]  Kai Yin,et al.  Netrin-1: An emerging player in inflammatory diseases. , 2022, Cytokine & growth factor reviews.

[3]  G. Kaspers,et al.  Outcome of pediatric acute myeloid leukemia (AML) in low- and middle-income countries: a systematic review of the literature , 2021, Expert review of anticancer therapy.

[4]  A. Stevens,et al.  Acute Myeloid Leukemia in Children: Emerging Paradigms in Genetics and New Approaches to Therapy , 2021, Current Oncology Reports.

[5]  Z. Mo,et al.  Keap1‐Nrf2 signaling pathway in angiogenesis and vascular diseases , 2020, Journal of tissue engineering and regenerative medicine.

[6]  Rabin Niroula,et al.  Acute Myeloid Leukemia: A Review. , 2020, Rhode Island medical journal.

[7]  A. Meissner,et al.  Netrin-1 promotes naive pluripotency through Neo1 and Unc5b co-regulation of Wnt and MAPK signalling , 2020, Nature Cell Biology.

[8]  Tran Kiem Hao,et al.  Long-term outcome of childhood acute myeloid leukemia: A 10-year retrospective cohort study , 2020, Pediatric reports.

[9]  Hyery Kim.  Treatments for children and adolescents with AML , 2019, Blood research.

[10]  Zheng Li,et al.  Netrin-1 promotes gastric cancer cell proliferation and invasion via the receptor neogenin through PI3K/AKT signaling pathway. , 2017, Oncotarget.

[11]  U. Kefeli,et al.  Netrin-1 in cancer: Potential biomarker and therapeutic target? , 2017, Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine.

[12]  Mario Cazzola,et al.  The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. , 2016, Blood.

[13]  De-Pei Liu,et al.  Netrin-1 suppresses the MEK/ERK pathway and ITGB4 in pancreatic cancer , 2016, Oncotarget.

[14]  Amitabh Singh,et al.  Leukemias in Children , 2015, The Indian Journal of Pediatrics.

[15]  D. Schlaepfer,et al.  FAK in cancer: mechanistic findings and clinical applications , 2014, Nature Reviews Cancer.

[16]  N. Renier,et al.  Structures of netrin-1 bound to two receptors provide insight into its axon guidance mechanism , 2014, Science.

[17]  T. Lion,et al.  Development of treatment and clinical results in childhood AML in Austria (1993–2013) , 2014, memo - Magazine of European Medical Oncology.

[18]  J. Keski‐Oja,et al.  NETRIN-4 Protects Glioblastoma Cells FROM Temozolomide Induced Senescence , 2013, PloS one.

[19]  C. H. Bell,et al.  Structure of the Repulsive Guidance Molecule (RGM)–Neogenin Signaling Hub , 2013, Science.

[20]  E. Mejstrikova,et al.  Development of treatment and clinical results in childhood acute myeloid leukemia in the Czech Republic , 2013, memo - Magazine of European Medical Oncology.

[21]  D. Johnston,et al.  Diagnosis and management of acute myeloid leukemia in children and adolescents: recommendations from an international expert panel. , 2012, Blood.

[22]  C. Dass,et al.  Netrin-1 in the developing enteric nervous system and colorectal cancer. , 2012, Trends in molecular medicine.

[23]  Bao-san Han,et al.  [Netrin-1 protein expression in gastric cancer and its correlation with clinicopathologic features and prognosis]. , 2011, Sichuan da xue xue bao. Yi xue ban = Journal of Sichuan University. Medical science edition.

[24]  D. Katsaros,et al.  Netrin-1 overexpression is predictive of ovarian malignancies , 2011, Oncotarget.

[25]  V. Castronovo,et al.  Netrin-1 mediates early events in pancreatic adenocarcinoma progression, acting on tumor and endothelial cells. , 2010, Gastroenterology.

[26]  S. Fulda.  Evasion of Apoptosis as a Cellular Stress Response in Cancer , 2010, International journal of cell biology.

[27]  L. Herfindal,et al.  Microcystin produces disparate effects on liver cells in a dose dependent manner. , 2006, Mini reviews in medicinal chemistry.

[28]  Li Yuan,et al.  The netrin receptor UNC5B mediates guidance events controlling morphogenesis of the vascular system , 2004, Nature.

[29]  Srikanth Rajagopalan,et al.  Neogenin mediates the action of repulsive guidance molecule , 2004, Nature Cell Biology.

[30]  O. Cussenot,et al.  Quantification of expression of netrins, slits and their receptors in human prostate tumors , 2003, International journal of cancer.

[31]  E. Estey,et al.  The anti‐apoptotic genes Bcl‐XL and Bcl‐2 are over‐expressed and contribute to chemoresistance of non‐proliferating leukaemic CD34+ cells , 2002, British journal of haematology.

[32]  Russell L Finley,et al.  Mediation of the DCC Apoptotic Signal by DIP13α* , 2002, The Journal of Biological Chemistry.

[33]  C. Sawyers,et al.  The phosphatidylinositol 3-Kinase–AKT pathway in human cancer , 2002, Nature Reviews Cancer.

[34]  F. Llambi,et al.  Netrin‐1 acts as a survival factor via its receptors UNC5H and DCC , 2001, The EMBO journal.

[35]  D. Bredesen,et al.  The dependence receptor DCC (deleted in colorectal cancer) defines an alternative mechanism for caspase activation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[36]  M. Vitek,et al.  Akt Activation Protects Hippocampal Neurons from Apoptosis by Inhibiting Transcriptional Activity of p53* , 2001, The Journal of Biological Chemistry.

[37]  B. Dörken,et al.  Constitutive expression levels of CD95 and Bcl‐2 as well as CD95 function and spontaneous apoptosis in vitro do not predict the response to induction chemotherapy and relapse rate in childhood acute lymphoblastic leukaemia , 2000, British journal of haematology.

[38]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[39]  F. McCormick,et al.  Phosphoinositide 3-OH Kinase (PI3K) and PKB/Akt Delay the Onset of p53-mediated, Transcriptionally Dependent Apoptosis* , 1999, The Journal of Biological Chemistry.

[40]  Mu-ming Poo,et al.  A Ligand-Gated Association between Cytoplasmic Domains of UNC5 and DCC Family Receptors Converts Netrin-Induced Growth Cone Attraction to Repulsion , 1999, Cell.

[41]  B. Hemmings.  Akt Signaling--Linking Membrane Events to Life and Death Decisions , 1997, Science.

[42]  J. Magaud,et al.  High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy. , 1993, Blood.

[43]  T. Renaud,et al.  Relapsed and Refractory Pediatric Acute Myeloid Leukemia: Current and Emerging Treatments , 2013, Pediatric Drugs.

[44]  J. Meyerhardt,et al.  Netrin-1: interaction with deleted in colorectal cancer (DCC) and alterations in brain tumors and neuroblastomas. , 1999, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.